Valeant Pharmaceuticals International's Bausch & Lomb Gets $39.5 Million From New Jersey To Move HQs
Valiant isn't the only one hiring, others are hiring too! Check it out! (Isn't it tempting?)
New Jersey economic development officials are giving Valeant Pharmaceuticals International Inc. $39.5 million to put its U.S. headquarters in the Garden State. Valeant completed an $8.7 billion acquisition of Bausch & Lomb in August. The pharmaceuticals firm said it would make the Rochester-based Bausch & Lomb the core of its eye-health business. But even before the deal closed, the Quebec company’s CEO, Michael Pearson, announced plans to make New Jersey Valeant’s U.S. eye-health base.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)
New Jersey economic development officials are giving Valeant Pharmaceuticals International Inc. $39.5 million to put its U.S. headquarters in the Garden State. Valeant completed an $8.7 billion acquisition of Bausch & Lomb in August. The pharmaceuticals firm said it would make the Rochester-based Bausch & Lomb the core of its eye-health business. But even before the deal closed, the Quebec company’s CEO, Michael Pearson, announced plans to make New Jersey Valeant’s U.S. eye-health base.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)